Stratec (ETR:SBS) PT Set at €77.00 by Berenberg Bank

Stratec (ETR:SBSGet Rating) received a €77.00 ($81.91) target price from Berenberg Bank in a report issued on Thursday, Borsen Zeitung reports. Berenberg Bank’s price objective would indicate a potential upside of 1.05% from the stock’s previous close.

A number of other research analysts have also weighed in on the company. Warburg Research set a €99.00 ($105.32) price target on Stratec in a research note on Friday, November 4th. Deutsche Bank Aktiengesellschaft set a €119.00 ($126.60) price target on Stratec in a research note on Wednesday, February 15th. Finally, Hauck Aufhäuser Investment Banking set a €97.00 ($103.19) price target on Stratec in a research note on Wednesday.

Stratec Trading Up 1.5 %

Shares of Stratec stock opened at €76.20 ($81.06) on Thursday. Stratec has a fifty-two week low of €72.70 ($77.34) and a fifty-two week high of €130.60 ($138.94). The firm has a market cap of $924.31 million, a PE ratio of 32.23, a P/E/G ratio of 10.43 and a beta of 0.30. The business’s fifty day moving average is €83.09 and its two-hundred day moving average is €83.37. The company has a quick ratio of 1.65, a current ratio of 3.48 and a debt-to-equity ratio of 38.79.

About Stratec

(Get Rating)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers.

Further Reading

Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.